Trademark: 79341934
Word
ABOMICS
Status
Registered
Status Code
700
Status Date
Tuesday, January 30, 2024
Serial Number
79341934
Registration Number
7292267
Registration Date
Tuesday, January 30, 2024
Mark Type
4000
Filing Date
Wednesday, April 27, 2022
Published for Opposition
Tuesday, November 14, 2023

Trademark Owner History
Abomics Oy - Original Registrant

Classifications
9 Downloadable computer software for access, viewing, recording, transmitting, processing, and visualization of medical data, pharmacogenetic data, and medicine data; Downloadable electronic databases containing structured medical data, pharmacogenetic data and medicine data, for use with computer software; Downloadable computer software for authorizing access to databases in the fields of pharmacogenetics and pharmaceuticals; Downloadable electronic databases featuring medical data in the field of pharmacogenetics, for use with computer software; Downloadable electronic databases featuring medical data in the field of pharmaceuticals, for use with computer software; Downloadable computer software and applications for access, viewing, recording, transmitting, and visualization of medical data, pharmacogenetic data and medicine data for use on mobile devices
44 Providing online medical record analysis services designed to provide patients and medical professionals with custom tailored information about the range of possible diagnoses and therapies associated with a defined set of symptoms other than in the field of dentistry; Providing online medical record analysis services designed to provide patients and medical professionals online clinical reports with information about medical conditions other than in the field of dentistry; Pharmaceutical advice, namely, providing online pharmacogenetic reports other than in the field of dentistry; Pharmaceutical advice; pharmaceutical advice, namely, providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; medical assistance; genetic testing for medical purposes; medical evaluation services for assessing effects and effectiveness of medical substances; Medical evaluation services for interpreting genes of patients to predict which drugs have the best opportunity for positive outcomes for patients, personalize medication selection and treatment choices for patients, identify potentially harmful drug reactions and calculate drug dosage adjustments for patients; medical counselling; medical information; medical analysis services relating to treatment of patients; DNA screening for medical purposes; providing information relating to medical services; medical analysis for the diagnosis and treatment of persons; medical and healthcare services related to DNA, genetics and genetic testing; medical and healthcare services related to DNA, genetics and genetic testing, namely, providing medical information to medical professionals in the form of reports in the field of pharmaceutical-gene interactions

Trademark Events
Jan 30, 2024
Notice Of Registration Confirmation Emailed
Jan 30, 2024
Registered-Principal Register
Nov 27, 2023
Notification Of Possible Opposition - Processed By Ib
Nov 14, 2023
Official Gazette Publication Confirmation E-Mailed
Nov 14, 2023
Published For Opposition
Nov 12, 2023
Notification Processed By Ib
Nov 8, 2023
Notification Of Possible Opposition Sent To Ib
Nov 8, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Oct 25, 2023
Notification Of Possible Opposition Sent To Ib
Oct 25, 2023
Notice Of Start Of Opposition Period Created, To Be Sent To Ib
Oct 25, 2023
Notification Of Notice Of Publication E-Mailed
Oct 12, 2023
Approved For Pub - Principal Register
Oct 10, 2023
Examiner's Amendment Entered
Oct 10, 2023
Examiners Amendment -Written
Oct 4, 2023
Teas/Email Correspondence Entered
Oct 4, 2023
Correspondence Received In Law Office
Oct 4, 2023
Teas Response To Office Action Received
Apr 24, 2023
Refusal Processed By Ib
Apr 4, 2023
Non-Final Action Mailed - Refusal Sent To Ib
Apr 4, 2023
Refusal Processed By Mpu
Feb 16, 2023
Non-Final Action (Ib Refusal) Prepared For Review
Feb 15, 2023
Non-Final Action Written
Feb 15, 2023
Assigned To Examiner
Jun 21, 2022
Application Filing Receipt Mailed
Jun 17, 2022
New Application Office Supplied Data Entered
Jun 10, 2022
Limitation From Original Application Entered
Jun 2, 2022
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24